Review article
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis: A literature review

https://doi.org/10.1016/j.jneuroim.2013.08.005Get rights and content

Highlights

  • HERV-W and related MSRV were reviewed in multiple sclerosis.

  • The debate on MSRV, endogenous or exogenous in nature?

  • HERV-W Env protein was also expressed in brain tissue from healthy subjects.

  • Absence of antibodies against MSRV Gag and Env proteins in multiple sclerosis

  • Reports do not support a causative role for MSRV or HERV-W in multiple sclerosis.

Abstract

Human endogenous retrovirus-W and the closely related multiple sclerosis-associated retrovirus have been associated with neuro-inflammatory diseases including multiple sclerosis. However, retroviral expression has been reported in brain tissue from healthy subjects as well. In addition, no consensus has been reached on the endogenous/exogenous status of multiple sclerosis-associated retrovirus, which also needs clarification. Therefore, the purpose of this study was to systematically review the published data available on the viruses investigated in patients with multiple sclerosis and to evaluate their hypothesized role as contributing factors to the disease etiology. Evidence suggests that both retroviruses may be endogenous to humans and that failure to suppress viral activity may not be restricted to patients with multiple sclerosis and therefore an unlikely cause of the disease.

Section snippets

Database search

A literature search was done on PubMed and Google Scholar and in total 21 publications met the criteria. The last update was on 14 June 2013. The following key words were used individually as well as in combination to do the search, multiple sclerosis, multiple sclerosis-associated retrovirus/human endogenous retrovirus-W and human endogenous retrovirus-W. The search terms (“multiple sclerosis” or “MS”) and (“multiple sclerosis associated retrovirus/human endogenous retrovirus-W” or

Criteria for the final selection of articles

The following articles were included in the review study: wherein data was derived from a sufficient sample size (15 or more patients with MS); data that included the required information for patients with MS, preferably with disease status stated (either in remission or with active disease), for healthy control subjects and/or patients with other neurological disorders (ONDs). The search was not limited by date or publication, but was limited to articles published in English.

Information extracted

Data was used to review reports on the detection rate of viral DNA, RNA, peptides/proteins and/or virions in the respective study populations. Methods used included PCR assays which were used for the molecular amplification of viral DNA or cDNA converted RNA and immuno detection was done with ELISA or immunohistochemistry to detect protein synthesis, while virions were visualized by electromicroscopy. The study populations consisted of patients with MS, both those in remission and with active

Possible bias

Bias in some of the reviewed studies has been present to some extent. The following may have affected reports to some degree: within studies different age groups as well as differences in the number of male and female participants recruited for the study and control groups may have biased findings. Between studies differences in race and ethnicity have not been well defined. Very few studies have used a large sample size and some studies have used rather small sample sizes.

Modification to protocol

Because of the relatively small number of publications on the endogenous retroviruses, a modification was needed wherein all studies that reported on MSRV/HERV-W on patients with MS were included, and with sample size numbers lower than 10 stated.

The debate around MSRV origin

The origin of MSRV as extracellular virus particles (Perron et al., 1989, Komurian-Pradel et al., 1999, Sotgiu et al., 2006) has been debated however. MSRV has been hypothesized to be an exogenous member of the HERV-W family (Perron et al., 2000, Tristem, 2000, Serra et al., 2001) and in this regard, HERVs have been reported to show resemblance to exogenous retroviruses (Ruprecht et al., 2008). Komurian-Pradel et al. (1999) and Perron et al. (2000) also suggested that MSRV may be a human

Terminology used in the current review

In their study, Ruprecht et al. (2008) use the term MSRV for nucleotide sequences and the proteins they encode obtained from extracellular particle-associated RNA and HERV-W for the endogenous retrovirus sequences present in the human genome. In the present review, however, because no consensus has been reached on the MSRV origin, the terms MSRV or MSRV/HERV-W and HERV-W will be used as reported but with respective investigated tissues noted. Results are given for MSRV and HERV-W gene sequences

MSRV in patients with MS and healthy controls

In general, RNA sequences have been reported using cDNA converted RNA as template for PCR amplification. Where techniques other than PCR have been used it has been stated.

MSRV sequences have been detected in human genomic DNA in peripheral blood leucocytes (PBLs), which suggests an endogenous retrovirus profile for MSRV, integrated into the human genome. Using fluorescence in situ hybridization (FISH), both Zawada et al. (2003) and Nowak et al. (2003) reported MSRV pol sequences not only

MSRV in patients with other neurological disorders

Nowak et al. (2003) reported MSRV pol RNA in PBL RNA from all patients with MS with active disease and in 70.6% of patients with other neurological disorders (ONDs). Mameli et al. (2007) reported MSRV/HERV-W (MSRV) env and pol RNA in RNA extracted from brain tissue from all patients with MS with active disease (N, 5) and also in all patients with OND (N, 6). These reports suggest that MSRV env and pol expressions in PBLs and brain tissue may not be specific to MS and therefore unlikely to be

HERV-W in patients with MS and healthy controls

Most studies have reported on HERV-W protein expression in brain tissue specifically but reports vary. Mameli et al. (2007), using immunohistochemistry, reported the detection of HERV-W Env protein in lesions in the brain from all patients with MS with active disease (N, 5) while none was detected in healthy control brain (N, 4). Perron et al. (2012), using immunohistology, detected HERV-W Env protein in macrophages within brain lesions in all patients with MS with active disease (N, 8) and

Conflict of interest

None declared.

References (34)

  • J.M. Antony et al.

    Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases

    AIDS Res. Hum. Retroviruses

    (2006)
  • G. Arru et al.

    Multiple sclerosis and HERV-W/MSRV: a multicentric study

    Int. J. Biomed. Sci.

    (2007)
  • J.L. Blond et al.

    Molecular characterization and placental expression of HERv-W, a new human endogenous retroviral family

    J. Virol.

    (1999)
  • J.N.P. De Villiers et al.

    Analysis of viral and genetic factors in South African patients with multiple sclerosis

    Metab. Brain Dis.

    (2006)
  • A. Dolei et al.

    The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics and immunology in human physiology and disease

    J. Neurovirol.

    (2009)
  • A. Dolei et al.

    Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients

    Neurology

    (2002)
  • M. Garcia-Montojo et al.

    The DNA copy number of human endogenous retrovirus-W (MSRV-type) Is increased in multiple sclerosis patients and is influenced by gender and disease severity

    PLoS One

    (2013)
  • Cited by (0)

    View full text